To explore possible downstream mechanisms by which METTL3 promotes SCLC chemoresistance, we applied RNA-seq and MeRIP-Seq to jointly identify downstream targets of METTL3-mediated m6A methylation. The gene discussed is METTL3; the disease is small cell lung carcinoma.